AOH1996 free base · Synonyms: AOH-1996 · AOH 1996
AOH1996 is an orally active ligand of replisome component PCNA (Proliferating cell nuclear antigen), targeting to transcription-replication conflict…
For research use only. Not for human or veterinary use.
AOH1996 structure
CAS No.: 2089314-64-5
Pack sizes & pricing
Description
AOH1996 is an orally active ligand of replisome component PCNA (Proliferating cell nuclear antigen), targeting to transcription-replication conflict (TRC).
Biological activity
In vitro Seven AML cell lines and primary CD34+CD38- leukemic stem cells (LSC) were treated with AOH1996 at concentrations of 0.5–1 μM for 24 hours, and cell proliferation, apoptosis, and colony formation assays were performed. AOH1996 dose-dependently inhibited proliferation and colony formation of AML cells and LSC, induced apoptosis, and had no significant effect on normal CD34+CD38- hematopoietic stem cells. In vivo Human primary AML cells were transplanted into Es1(ko)SCID mice, and 7 days later, AOH1996 (100 mg/kg) was administered by oral gavage twice daily for 3 weeks. AOH1996 significantly reduced leukemia burden in peripheral blood and spleen, and extended median survival from 35 days to 50 days; secondary transplantation confirmed reduced LSC burden, with survival extended from 30 days to 42 days.
Identifiers
- SMILES
-
O=C(NCC(NC1=C(C=CC=C1)OC2=CC=CC(OC)=C2)=O)C3=CC=CC4=C3C=CC=C4 - InChIKey
-
HDMONPHKMIZXDH-UHFFFAOYSA-N
Specifications
- MW (average)
- 426.4639
- Formula
- C26H22N2O4
- CAS No.
- 2089314-64-5
- Physical state
- Solid
- Color
- White to off-white
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
Documents
References
Same research area
Search Cancer- BP-00006 SLF Exclusive free base · >98%
- BP-00008 NSC-339004 free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00020 PT262 free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00024 KX2-361 free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%